Ciprolet, 500 mg 10 pcs

Name: Ciprolet, 500 mg 10 pcs
SKU: 28013
Availability: InStock

€3.23

EAN: 8901148010017 SKU: 28013 Categories: Medicine, Trichomoniasis and malaria

Description

Skin infections, Intestinal infections, Sinusitis, Urinary tract infections, Infectious diseases, Haymorrhynchitis, Biliary tract infections, Prostate, Bronchitis, Respiratory tract infections, Lung inflammation (pneumonia), Osteomyelitis, Otitis Uncomplicated and complicated infections caused by microorganisms sensitive to ciprofloxacin.
Adults
– respiratory tract infections. Ciprofloxacin is recommended for pneumonias caused by Klebsiella spp.,
Enterobacter spp., Proteus spp., Escherichia coli, Pseudomonas aeruginosa, Haemophilus spp, Moraxella catarrhalis,
Legionella spp. and staphylococci;
– middle ear infections (otitis media), sinus infections (sinusitis), especially if these infections are caused by gram-negative microorganisms, including Pseudomonas aeruginosa or staphylococci;
– eye infections;
–
– kidney and/or urinary tract infections;
– genital infections, including adnexitis, gonorrhea, prostatitis;
– abdominal infections (bacterial infections of the gastrointestinal tract, biliary tract, peritonitis);
– skin and soft tissue infections;
– sepsis;
– infections or prophylaxis of infections in immunocompromised patients (patients taking immunosuppressants or patients with neutropenia);
– infections and prophylaxis of infections in patients with immune system disorders. – Selective intestine decontamination in immunocompromised patients;
– Prophylaxis and treatment of inhalational anthrax (infection with Bacillus anthracis);
– Prophylaxis of invasive infections caused by Neisseria meningitidis.
It is necessary to take into account the current official guidelines on the rules of antibacterial drugs.
Children
– treatment of complications caused by Pseudomonas aeruginosa in children with pulmonary cystic fibrosis from 5 to 17 years;
– prevention and treatment of pulmonary anthrax (infection with Bacillus anthracis).

Active ingredient

Ciprofloxacin

Composition

1 coated tablet contains ciprofloxacin hydrochloride monohydrate in a dose,

How to take, the dosage

The dose of Ciprolet depends on the severity of the disease, type of infection, body condition, age, body weight and renal function.

In uncomplicated renal and urinary tract diseases, 250 mg 2 times a day, and in severe cases – 500 mg 2 times a day.

In moderate lower respiratory tract diseases, 250 mg 2 times a day, and in more severe cases, 500 mg 2 times a day.

A single administration of Ciprolet® in a dose of 250-500 mg is recommended for treatment of gonorrhea.

In gynecological diseases, enteritis and colitis with severe course and high fever, prostatitis,

Osteomyelitis, 500 mg 2 times a day is indicated (for treatment of common diarrhea a dose of 250 mg 2 times a day can be used).

The tablets should be taken on an empty stomach with plenty of fluid.

The duration of treatment depends on the severity of the disease, but treatment should always continue for at least 2 more days after symptoms disappear.

The duration of treatment is usually 7-10 days.

Interaction

In concomitant use of Ciprolet with didanosine absorption of ciprofloxacin is reduced due to the formation of complexes of ciprofloxacin with aluminum and magnesium salts contained in didanosine.

Concomitant administration of Ciprolet and theophylline may lead to increased plasma concentrations of theophylline due to competitive inhibition at cytochrome P450 binding sites, which leads to increased T1/2 of theophylline and increased risk of theophylline-associated toxic effects.

The simultaneous administration of antacids as well as agents containing aluminum, zinc, iron, or magnesium ions may decrease absorption of ciprofloxacin; therefore, the interval between administration of these agents should be at least 4 hours.

The simultaneous use of Ciprolet and anticoagulants prolongs bleeding time.

In concomitant use of Ciprolet and cyclosporine the nephrotoxic effect of the latter is increased.

Special Instructions

Severe infections, staphylococcal infections and infections caused by gram-positive and anaerobic bacteria
In the treatment of severe infections, staphylococcal infections and infections caused by anaerobic bacteria,

ciprofloxacin should be used in combination with appropriate antibacterial agents.

Synopsis

White or almost white round biconvex tablets with smooth surface on both sides, covered with a film coating.
Appearance at breakage – white or almost white mass.

Contraindications

Hypersensitivity to ciprofloxacin or other drugs from the group of fluoroquinolones,

as well as to excipients (see section “Composition”).

Side effects

The adverse reactions listed below were classified as follows:
“very frequent” (>1/10 appointments), “frequent” (1/10 to 1/100 appointments),
“infrequent” (1/100 to 1/1000 appointments), “rare” (1/1000 to 1/10 000 appointments),

“very rare” (<1/10 000 appointments), “often unknown”.

Overdose

Treatment: the patient’s condition should be closely monitored, gastric lavage should be performed, the usual first aid measures should be carried out, and adequate fluid intake should be ensured.

Little (less than 10%) of the drug may be eliminated by hemo- or peritoneal dialysis.

The specific antidote is unknown.

Pregnancy use

The safety of using ciprofloxacin in pregnant women has not been established.

Similarities

Ciprofloxacin, Ciprolet, Cifran, Ciprofloxacin, Cipromed, Cifran OD, Ciprofloxacin Ecocifol, Ciprofloxacin, Cipromed, Ciprofloxacin Teva, Ciprofloxacin Renewal

Additional information

Weight	0.016 kg
Shelf life	3 years.
Conditions of storage	In the light-protected place at a temperature not exceeding 25 ° C.
Manufacturer	Dr. Reddy's, India
Medication form	pills
Brand	Dr. Reddy's